Skip to main content
. 2018 Dec 4;2018(12):CD013186. doi: 10.1002/14651858.CD013186
Index test Studies Cases/Number of participants Summary sensitivity (95% CI) % Summary specificity (95% CI) %
Primary target condition: Invasive melanoma andatypical intraepidermal melanocytic variants
MSI‐CAD 7 281/2389 93.7 (83.9 to 97.7) 41.7 (22.0 to 64.6)
Derm‐CAD 19 955/8403 88.5 (81.3 to 93.1) 71.3 (60.0 to 80.4)
DB–MIPS 4 427/1479 96.4 (84.9 to 99.2) 85.5 (75.7 to 91.7)
MelaFind 4 191/1786 97.9 (94.6 to 99.2) 24.8 (8.82 to 52.9)
Secondary target condition: Invasive melanoma alone
MSI‐CAD 4 80/256 83.1 (26.5 to 98.5) 66.9 (41.6 to 85.1)